You are here

Ishwaria Subbiah (US)

Cancer remains a disease that disproportionately affects older people. Despite accounting for the greatest proportion of those with cancer, older patients represent a significantly lower proportion of patients included in clinical trials. The care of older adults with cancers calls for a substantial understanding of the intricacies of supportive care and geriatrics, oncology as well as phase I/II clinical trial design. Dr. Subbiah is uniquely qualified for this role, having acquired this essential knowledge through her training at MD Anderson first as a Fellow in the Department of Investigational Cancer Therapeutics (A Phase I Program), then in Medical Oncology in the Division of Cancer Medicine and most recently in Department of Palliative, Rehabilitation, and Integrative Medicine. Dr. Subbiah has a thorough understanding of phase I and II clinical trial design, novel therapeutics including immunotherapy and targeted therapies, fundamentals of medical oncology practice and symptom management. With this robust foundation, she cultivates a clinical practice and research focus on symptom management in all patients with particular emphasis on the older adults.

November 18, 2018
2:00pm to 3:30pm Emerging technologies in diagnosis and care Room E 102 Esther Bastiaannet (NL), Ishwaria Subbiah (US), Nienke de Glas (NL), Daniël Souwer (NL), Romain Corre (FR), Tina Hsu (CA)